DSPA-ALPHA - PROPERTIES OF THE PLASMINOGEN ACTIVATORS OF THE VAMPIRE BAT DESMODUS-ROTUNDUS

被引:22
作者
GULBA, DC [1 ]
PRAUS, M [1 ]
WITT, W [1 ]
机构
[1] SCHERING AG, DIV CARDIOVASC PHARMACOL, D-13342 BERLIN, GERMANY
关键词
D O I
10.1016/S0268-9499(08)80020-3
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The saliva of the vampire bat Desmodus rotundus contains a family of potent plasminogen activators, which were named DSPAs after their original source (Desmodus salivary plasminogen activators), The DSPAs share a high structural homology with t-PA, Four different variants of DSPA have been discovered, called DSPA alpha(1), alpha(2), beta and gamma, out of which, for its unique thrombolytic properties, DSPA alpha(1) has been selected for further development, It has a high potential to develop into a third generation thrombolytic drug. DSPA alpha(1) is a protein with high thrombolytic potency and efficacy, Unlike all other plasminogen activators currently in use, it is almost completely fibrin specific, Furthermore, its prolonged half-life seems to warrant single bolus administration, Above all, recanalization with DSPA alpha(1) seems to occur more rapidly and more completely and, unlike with other plasminogen activators, is sustained over prolonged time periods, Despite being a non human protein its antigenicity is low and only repeated administrations of the substance in short time intervals may non consistently produce low titers of nan neutralizing antibodies, The favorable thrombolytic profile of DSPA alpha(1) warrants studying in future thrombolytic trials.
引用
收藏
页码:91 / 96
页数:6
相关论文
共 32 条
[1]  
[Anonymous], 1987, Lancet, V2, P871
[2]  
[Anonymous], 1988, LANCET, V2, P349
[3]  
BERGUM PW, 1992, J BIOL CHEM, V267, P17726
[4]  
BURTON G, 1993, THROMB HAEMOSTASIS, V69, P842
[5]   IMPORTANCE OF CONTINUED ACTIVATION OF THROMBIN REFLECTED BY FIBRINOPEPTIDE-A TO THE EFFICACY OF THROMBOLYSIS [J].
EISENBERG, PR ;
SHERMAN, L ;
RICH, M ;
SCHWARTZ, D ;
SCHECHTMAN, K ;
GELTMAN, EM ;
SOBEL, BE ;
JAFFE, AS .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1986, 7 (06) :1255-1262
[6]   PARADOXIC ELEVATION OF FIBRINOPEPTIDE A AFTER STREPTOKINASE - EVIDENCE FOR CONTINUED THROMBOSIS DESPITE INTENSE FIBRINOLYSIS [J].
EISENBERG, PR ;
SHERMAN, LA ;
JAFFE, AS .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1987, 10 (03) :527-529
[7]  
GARDELL SJ, 1989, J BIOL CHEM, V264, P17947
[8]   EFFECTIVE THROMBOLYSIS WITHOUT MARKED PLASMINEMIA AFTER BOLUS INTRAVENOUS ADMINISTRATION OF VAMPIRE BAT SALIVARY PLASMINOGEN-ACTIVATOR IN RABBITS [J].
GARDELL, SJ ;
RAMJIT, DR ;
STABILITO, II ;
FUJITA, T ;
LYNCH, JJ ;
CUCA, GC ;
JAIN, D ;
WANG, SP ;
TUNG, J ;
MARK, GE ;
SHEBUSKI, RJ .
CIRCULATION, 1991, 84 (01) :244-253
[9]  
GARDELL SJ, 1992, FIBRINOLYSIS S2, V6, P28
[10]   INCREASED THROMBIN LEVELS DURING THROMBOLYTIC THERAPY IN ACUTE MYOCARDIAL-INFARCTION - RELEVANCE FOR THE SUCCESS OF THERAPY [J].
GULBA, DC ;
BARTHELS, M ;
WESTHOFFBLECK, M ;
JOST, S ;
RAFFLENBEUL, W ;
DANIEL, WG ;
HECKER, H ;
LICHTLEN, PR .
CIRCULATION, 1991, 83 (03) :937-944